Clinical Cardiology 912 - Clinical Cardiology Alert - Dec 01, 2005

Target Audience:

This activity is intended for the cardiologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Clinical Cardiology
University of California
San Francisco

Editorial Board Members
John DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia

Jonathan Abrams, MD
Professor of Medicine
Division of Cardiology
University of New Mexico


  • CT Coronary Angiography
  • Effective Aspirin Dose
  • Colchicine for Acute Pericarditis
  • Outcomes and the Volume of Cardioverter-Defibrillator Implants Performed
  • High Sensitivity C-Reactive Protein Predicts Recurrence of Atrial Fibrillation
  • More Data From PROVE IT-TIMI 22


  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert's physician editor, Michael H. Crawford, MD, is on the speaker's bureau for Pfizer. Editorial board member John DiMarco, MD, PhD is a consultant for Novartis, and does research for Medtronic and Guidant. Editorial board member Jonathan Abrams, MD serves on the speaker’s bureau for Merck, Pfizer, and Parke-Davis.

Copyright 2006 AHC Media. All rights reserved.